Reply to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology

Detalles Bibliográficos
Autores principales: Raje, Noopur, Terpos, Evangelos, Jandial, Danielle D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631159/
https://www.ncbi.nlm.nih.gov/pubmed/31100871
http://dx.doi.org/10.3390/dj7020054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631159/
https://www.ncbi.nlm.nih.gov/pubmed/31100871
http://dx.doi.org/10.3390/dj7020054

Ejemplares similares